• All Categories
  • Infectious Diseases
  • Rare Diseases
  • Dermatology
  • Oncology
  • Respiratory
  • Pain
  • Neurology
  • Cardiovascular
  • News
Controversial ALS drug approved by FDAControversial ALS drug approved by FDA
Controversial ALS drug approved by FDA

New but controversial ALS drug, Relyviro, approved by FDA

Dec 1, 2022 News
Merger planned between Bio-Rad and QiagenMerger planned between Bio-Rad and Qiagen
Merger planned between Bio-Rad and Qiagen

Bio-Rad and Qiagen plan to merge in a deal potentially worth over $10bn

Dec 1, 2022 News
AstraZeneca’s liver cancer treatment gets FDA approvalAstraZeneca’s liver cancer treatment gets FDA approval
AstraZeneca’s liver cancer treatment gets FDA approval

FDA approves AstraZeneca's liver cancer treatment

Dec 1, 2022 News
Furosemide approved by FDA for patients with chronic heart failureFurosemide approved by FDA for patients with chronic heart failure
Furosemide approved by FDA for patients with chronic heart failure

FDA approves Furosemide to treat patients with chronic heart failure

Dec 1, 2022 News
Cancer vaccine may be available by 2030Cancer vaccine may be available by 2030
Cancer vaccine may be available by 2030

New cancer vaccine may be available by 2030

Dec 1, 2022 News
Johnson & Johnson to buy Abiomed for $17bnJohnson & Johnson to buy Abiomed for $17bn
Johnson & Johnson to buy Abiomed for $17bn

Johnson & Johnson is planning to acquire Abiomed for $17bn

Dec 1, 2022 News
Gilead and MacroGenics partner for bispecific antibody developmentGilead and MacroGenics partner for bispecific antibody development
Gilead and MacroGenics partner for bispecific antibody development

Gilead Sciences and Macrogenics partner for bispecific antibody development

Dec 1, 2022 News
FDA announces recall of two blood pressure pills over cancer riskFDA announces recall of two blood pressure pills over cancer risk
FDA announces recall of two blood pressure pills over cancer risk

FDA recalls two blood pressure pills due to risk that they may cause cancer

Dec 1, 2022 News
FDA clears GSK’s Boostrix for use in pregnancyFDA clears GSK’s Boostrix for use in pregnancy
FDA clears GSK’s Boostrix for use in pregnancy

FDA approves GSK's whooping cough vaccine, Boostrix, for use in pregnant patients

Dec 1, 2022 News
Potentially cancer-stopping pill given to first patientPotentially cancer-stopping pill given to first patient
Potentially cancer-stopping pill given to first patient

New pill which may halt cancer is given to first patient in a trial

Dec 1, 2022 News
Rising to the unique challenges of rare diseasesRising to the unique challenges of rare diseases
Rising to the unique challenges of rare diseases

Aaron Bean at Veeva explores the challenges of rare diseases: With up to 30 million people in EU living with rare diseases, Veeva discusses the challenges facing these rare diseases

Dec 1, 2022 Rare Diseases
Pharmafile EVENTSPharmafile EVENTS
Pharmafile EVENTS

Pharmafile Events 2022-2023

Dec 1, 2022